Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection

Overview of attention for article published in Virology Journal, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 13,425 followers.

RT @monarchdiaries: I’ve been interested in the irreversible serine protease inhibitor AEBSF (PMSF’s non-lethal relative) as a #SARSCoV2 ce…

I’ve been interested in the irreversible serine protease inhibitor AEBSF (PMSF’s non-lethal relative) as a #SARSCoV2 cell entry blocker. It’s being evaluated as such (along with A1AT). @__ice9 @gstanchev https://t.co/R6iEEexT5s https://t.co/CjJ2XQxdu8

RT @VirologyJ: RSV entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection https://t.co/2lTq7…

RT @VirologyJ: RSV entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection https://t.co/2lTq7…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.